BACKGROUND: Aspiration pneumonia is a common syndrome, although less well characterized than other pneumonia syndromes. We describe a large population of patients with aspiration pneumonia. METHODS: In this retrospective population study, we queried the electronic medical records at a tertiary-care, university-affiliated hospital from 1996 to 2006. Patients were initially identified by International Classification of Diseases, 9th Revision code 507.x; subsequent physician chart review excluded patients with aspiration pneumonitis and those without a confirmatory radiograph. Patients with community-acquired aspiration pneumonia were compared to a contemporaneous population of community-acquired pneumonia (CAP) patients. We compared CURB-65 (a clinical prediction rule based on Confusion, Uremia, Respiratory rate, Blood Pressure, and age)-predicted mortality with actual 30-day mortality. RESULTS: We identified 628 patients with aspiration pneumonia, of which 510 were community-acquired. Median age was 77 years, with 30-day mortality of 21%. Compared to CAP patients, patients with community-acquired aspiration pneumonia had more frequent inpatient admission (99% vs 58%) and intensive care unit admission (38% vs 14%), higher Charlson comorbidity index (3 vs 1), and higher prevalence of do not resuscitate/intubate orders (24% vs 11%). CURB-65 predicted mortality poorly in aspiration pneumonia patients (area under the curve, 0.66). CONCLUSIONS: Patients with community-acquired aspiration pneumonia are older, have more comorbidities, and demonstrate higher mortality than CAP patients, even after adjustment for age and comorbidities. CURB-65 poorly predicts mortality in this population.
BACKGROUND:Aspiration pneumonia is a common syndrome, although less well characterized than other pneumonia syndromes. We describe a large population of patients with aspiration pneumonia. METHODS: In this retrospective population study, we queried the electronic medical records at a tertiary-care, university-affiliated hospital from 1996 to 2006. Patients were initially identified by International Classification of Diseases, 9th Revision code 507.x; subsequent physician chart review excluded patients with aspiration pneumonitis and those without a confirmatory radiograph. Patients with community-acquired aspiration pneumonia were compared to a contemporaneous population of community-acquired pneumonia (CAP) patients. We compared CURB-65 (a clinical prediction rule based on Confusion, Uremia, Respiratory rate, Blood Pressure, and age)-predicted mortality with actual 30-day mortality. RESULTS: We identified 628 patients with aspiration pneumonia, of which 510 were community-acquired. Median age was 77 years, with 30-day mortality of 21%. Compared to CAPpatients, patients with community-acquired aspiration pneumonia had more frequent inpatient admission (99% vs 58%) and intensive care unit admission (38% vs 14%), higher Charlson comorbidity index (3 vs 1), and higher prevalence of do not resuscitate/intubate orders (24% vs 11%). CURB-65 predicted mortality poorly in aspiration pneumoniapatients (area under the curve, 0.66). CONCLUSIONS:Patients with community-acquired aspiration pneumonia are older, have more comorbidities, and demonstrate higher mortality than CAPpatients, even after adjustment for age and comorbidities. CURB-65 poorly predicts mortality in this population.
Authors: Ali A El-Solh; Celestino Pietrantoni; Abid Bhat; Alan T Aquilina; Mifue Okada; Vikas Grover; Nancy Gifford Journal: Am J Respir Crit Care Med Date: 2003-04-10 Impact factor: 21.405
Authors: W S Lim; M M van der Eerden; R Laing; W G Boersma; N Karalus; G I Town; S A Lewis; J T Macfarlane Journal: Thorax Date: 2003-05 Impact factor: 9.139
Authors: Jeffrey H Kozlow; Sean M Berenholtz; Elizabeth Garrett; Todd Dorman; Peter J Pronovost Journal: Crit Care Med Date: 2003-07 Impact factor: 7.598
Authors: Michael J Lanspa; Paula Peyrani; Timothy Wiemken; Emily L Wilson; Julio A Ramirez; Nathan C Dean Journal: J Hosp Med Date: 2014-11-01 Impact factor: 2.960
Authors: Luis F Giraldo-Cadavid; Javier Burguete; Felipe Rueda; Ana M Galvis; Natalia Castaneda; Luis M Agudelo-Otalora; William D Moscoso; Nelson Paez; Secundino Fernandez Journal: Eur Arch Otorhinolaryngol Date: 2017-03-24 Impact factor: 2.503
Authors: Samuel M Brown; Abhijit Duggal; Peter C Hou; Mark Tidswell; Akram Khan; Matthew Exline; Pauline K Park; David A Schoenfeld; Ming Liu; Colin K Grissom; Marc Moss; Todd W Rice; Catherine L Hough; Emanuel Rivers; B Taylor Thompson; Roy G Brower Journal: Crit Care Med Date: 2017-08 Impact factor: 7.598
Authors: Beibei Xu; Isabel J Boero; Lindsay Hwang; Quynh-Thu Le; Vitali Moiseenko; Parag R Sanghvi; Ezra E W Cohen; Loren K Mell; James D Murphy Journal: Cancer Date: 2014-12-23 Impact factor: 6.860
Authors: Barbara E Jones; Dave S Collingridge; Caroline G Vines; Herman Post; John Holmen; Todd L Allen; Peter Haug; Charlene R Weir; Nathan C Dean Journal: Appl Clin Inform Date: 2019-01-02 Impact factor: 2.342
Authors: Daniel B Knox; Michael J Lanspa; Cristina M Pratt; Kathryn G Kuttler; Jason P Jones; Samuel M Brown Journal: J Crit Care Date: 2014-05-28 Impact factor: 3.425
Authors: Samuel M Brown; Colin K Grissom; Marc Moss; Todd W Rice; David Schoenfeld; Peter C Hou; B Taylor Thompson; Roy G Brower Journal: Chest Date: 2016-01-19 Impact factor: 9.410
Authors: Joanna Thomson; Matt Hall; Lilliam Ambroggio; Jay G Berry; Bryan Stone; Rajendu Srivastava; Samir S Shah Journal: J Hosp Med Date: 2019-11-20 Impact factor: 2.960